John Zuris

John Zuris

Company: Editas Medicine

Job title: Director, Editing Technologies


Presenting SLEEK: a Highly Efficient Knock-In Technology for Next-Generation Cellular Medicines 9:30 am

Illuminating a greater than 90% knock-in efficiency across clinically relevant cell types to ensure guaranteed robust expression of single and multiple transgene cargos Demonstrating equal efficiency with both viral and non-viral DNA donor templates to provide a manufacturing advantage for enhanced scalability Weaponizing the next generation of iPSC-derived NK cells (iNKs) with robust tumor killing…Read more

day: Next-Generation Engineering Focus Day
day: Pre-Conference Day AM 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.